Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology.
Please direct podcast-related inquiries to [email protected].
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
Please direct podcast-related inquiries to [email protected].
Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.
- Update frequency
- every 5 days
- Average duration
- 21 minutes
- Episodes
- 160
- Years Active
- 2020 - 2025
Latest Updates on Diabetes Management in Pregnancy
In this episode, the hosts break down a pair of recent studies published in JAMA examining use of non-insulin agents in the management of diabetes during pregnancy.
Episode Highlights
00:05 Intro
00…
00:19:42 |
Mon 08 Jan 2024
Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes
Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies mean for future of type 1 diabetes management.
Epi…
00:18:18 |
Wed 03 Jan 2024
Diabetes Dialogue: 2023 Top Episodes Recap
To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has shaped the future of diabetes management.
Episode …
00:30:22 |
Mon 01 Jan 2024
Key Updates in ADA Standards of Care—2024
Hosts discuss what they consider the most significant or relevant updates in the ADA's Standards of Care—2024, with a focus on new recommendations for glycemic management, bone health, immunizations,…
00:23:21 |
Fri 29 Dec 2023
Diabetes Technology Updates and Standards of Care—2024
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the latest in diabetes technology from Decembe…
00:22:55 |
Tue 19 Dec 2023
SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023
In this episode, hosts take a deep dive into the study’s results, including secondary endpoints, and what it means for the care of patients with overweight or obesity and preexisting cardiovascular d…
00:16:05 |
Sat 11 Nov 2023
Tirzepatide (Zepbound) Approved for Chronic Weight Management
In this episode, hosts discuss the FDA's approval of tirzeptiade (Zepbound) as an adjunct to lifestyle modification for the chronic weight management in people with overweight or obesity.
00:14:34 |
Wed 08 Nov 2023
Diabetes Dialogue: Automated Insulin Delivery News in October 2023
In this episode, hosts discuss the FDA clearance of the Omnipod 5 App for iPhones and a pair of studies examining use of automated insulin delivery systems.
00:24:55 |
Wed 01 Nov 2023
SURMOUNT-3 and SURMOUNT-4 Data
In this episode, hosts discuss the results of SURMOUNT-3 and SURMOUNT-4 as well as how it might help inform use of tirzepatide if approved by the US Food and Drug Administration for chronic weight ma…
00:21:55 |
Fri 27 Oct 2023
PROTECT Data and Teplizumab in Newly Diagnosed T1D
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diagnosed type 1 diabetes.
00:14:48 |
Wed 25 Oct 2023
Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical
In this episode, hosts discuss a pair of topics making headlines in recent weeks: the US Food and Drug Administration’s 510(k) clearance for the Accu-Chek Solo micropump system and Abbott’s acquisiti…
00:21:42 |
Tue 19 Sep 2023
Making Sense of Semaglutide in Type 1 Diabetes
In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, including the implications of the findings and th…
00:17:46 |
Fri 08 Sep 2023
Clearance of Tandem Mobi and Welldoc's BlueStar Platform
Hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for people with diabetes and care providers.
…
…
00:21:21 |
Sat 02 Sep 2023
Addressing Health Disparities with Diabetes Technology, with Etty Vider, PharmD
Hosts are joined by Etty Vider, PharmD, for a nuanced discussion surrounding leveraging diabetes technology to improve care for people with diabetes, including exploring strategies for improving the …
00:18:54 |
Sat 02 Sep 2023
What Medicare Drug Price Negotiations Mean for Diabetes
In this special edition episode, hosts break down what the announcement of the 10 drugs selected for Medicare price negotiations under the Inflation Reduction Act means for providers and people with …
00:16:32 |
Tue 29 Aug 2023
Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of individualizing nutrition in diabetes management, a…
00:25:52 |
Wed 23 Aug 2023
Diabetes Dialogue: Implications of SELECT Trial and Brenzavvy on Cost Plus Drugs
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexagliflozin to the Cost Plus Drugs platform and top…
00:33:19 |
Wed 23 Aug 2023
Diabetes Dialogue: ADCES 2023 Recap
In this episode, which is the first of multiple special edition ADCES 2023 episodes, hosts hold an overarching discussion of the meeting itself and major themes from the ADCES's 50th-anniversary cele…
00:22:21 |
Wed 23 Aug 2023
Diabetes Dialogue: ADA 2023 Recap
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss their top takeaways from ADA 2023.
Video v…
Video v…
00:33:25 |
Wed 23 Aug 2023
Diabetes Dialogue: Latest News in Insulin Delivery, with Gary Scheiner, MS
Hosts are joined by Gary Scheiner, MS, of Integrated Diabetes Services, to discuss the latest developments in diabetes technology from the floor of the 83rd Scientific Sessions of the American Diabet…
00:24:17 |
Wed 23 Aug 2023
Disclaimer: The podcast and artwork embedded on this page are the property of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives. This content is not affiliated with or endorsed by eachpod.com.